Monday, December 23, 2024
HomeTagsCANbridge

CANbridge

CANbridge Pharmaceuticals CAN108 New Drug Application (NDA) for Alagille Syndrome Accepted by China’s National Medical Products Administration

CANbridge Pharmaceuticals Inc., (“CANbridge,” stock code 1228.HK) a leading China-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics